▶ 調査レポート

日本脳炎ワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Japanese Encephalitis (JE) Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。日本脳炎ワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Japanese Encephalitis (JE) Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-09063資料のイメージです。• レポートコード:D005-09063
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥379,320 (USD3,480)▷ お問い合わせ
  Multi User¥568,980 (USD5,220)▷ お問い合わせ
  Corporate User¥758,640 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、日本脳炎ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。日本脳炎ワクチンの種類別市場規模(不活化ワクチン、弱毒生ワクチン)、用途別市場規模(公共用、個人用)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GSK、Bharat Biotech、Wuhan Institute of Biological、Sanofi、Valneva、Chengdu institute of biologica、Liaoning Chengda、Beijing Taitan、Lanzhou Institute of Biological、Biological E. Limited
・地域別グローバル市場分析 2015年-2020年
・日本脳炎ワクチンの北米市場(アメリカ、カナダ、メキシコ)
・日本脳炎ワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・日本脳炎ワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・日本脳炎ワクチンの南米市場(ブラジル、アルゼンチン)
・日本脳炎ワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:不活化ワクチン、弱毒生ワクチン
・用途別分析:公共用、個人用
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Japanese Encephalitis (JE) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Japanese Encephalitis (JE) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Japanese Encephalitis (JE) Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Japanese Encephalitis (JE) Vaccine market has been segmented into
Inactivated Vaccine
Live Attenuated Vaccine

By Application, Japanese Encephalitis (JE) Vaccine has been segmented into:
Public
Private

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Japanese Encephalitis (JE) Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Japanese Encephalitis (JE) Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Japanese Encephalitis (JE) Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Japanese Encephalitis (JE) Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Japanese Encephalitis (JE) Vaccine Market Share Analysis
Japanese Encephalitis (JE) Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Japanese Encephalitis (JE) Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Japanese Encephalitis (JE) Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Japanese Encephalitis (JE) Vaccine are:
GSK
Bharat Biotech
Wuhan Institute of Biological
Sanofi
Valneva
Chengdu institute of biologica
Liaoning Chengda
Beijing Taitan
Lanzhou Institute of Biological
Biological E. Limited

Among other players domestic and global, Japanese Encephalitis (JE) Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Japanese Encephalitis (JE) Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Japanese Encephalitis (JE) Vaccine, with price, sales, revenue and global market share of Japanese Encephalitis (JE) Vaccine in 2018 and 2019.
Chapter 3, the Japanese Encephalitis (JE) Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Japanese Encephalitis (JE) Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Japanese Encephalitis (JE) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Japanese Encephalitis (JE) Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Japanese Encephalitis (JE) Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Japanese Encephalitis (JE) Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Japanese Encephalitis (JE) Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public
1.3.3 Private
1.4 Overview of Global Japanese Encephalitis (JE) Vaccine Market
1.4.1 Global Japanese Encephalitis (JE) Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bharat Biotech
2.2.1 Bharat Biotech Details
2.2.2 Bharat Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bharat Biotech SWOT Analysis
2.2.4 Bharat Biotech Product and Services
2.2.5 Bharat Biotech Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Wuhan Institute of Biological
2.3.1 Wuhan Institute of Biological Details
2.3.2 Wuhan Institute of Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Wuhan Institute of Biological SWOT Analysis
2.3.4 Wuhan Institute of Biological Product and Services
2.3.5 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Valneva
2.5.1 Valneva Details
2.5.2 Valneva Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Valneva SWOT Analysis
2.5.4 Valneva Product and Services
2.5.5 Valneva Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Chengdu institute of biologica
2.6.1 Chengdu institute of biologica Details
2.6.2 Chengdu institute of biologica Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Chengdu institute of biologica SWOT Analysis
2.6.4 Chengdu institute of biologica Product and Services
2.6.5 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Liaoning Chengda
2.7.1 Liaoning Chengda Details
2.7.2 Liaoning Chengda Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Liaoning Chengda SWOT Analysis
2.7.4 Liaoning Chengda Product and Services
2.7.5 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beijing Taitan
2.8.1 Beijing Taitan Details
2.8.2 Beijing Taitan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beijing Taitan SWOT Analysis
2.8.4 Beijing Taitan Product and Services
2.8.5 Beijing Taitan Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Lanzhou Institute of Biological
2.9.1 Lanzhou Institute of Biological Details
2.9.2 Lanzhou Institute of Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Lanzhou Institute of Biological SWOT Analysis
2.9.4 Lanzhou Institute of Biological Product and Services
2.9.5 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biological E. Limited
2.10.1 Biological E. Limited Details
2.10.2 Biological E. Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biological E. Limited SWOT Analysis
2.10.4 Biological E. Limited Product and Services
2.10.5 Biological E. Limited Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Japanese Encephalitis (JE) Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Japanese Encephalitis (JE) Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Japanese Encephalitis (JE) Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Japanese Encephalitis (JE) Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Japanese Encephalitis (JE) Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Japanese Encephalitis (JE) Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Japanese Encephalitis (JE) Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Japanese Encephalitis (JE) Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Japanese Encephalitis (JE) Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
6.4 France Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Japanese Encephalitis (JE) Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Japanese Encephalitis (JE) Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
7.5 India Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Japanese Encephalitis (JE) Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Japanese Encephalitis (JE) Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Japanese Encephalitis (JE) Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Japanese Encephalitis (JE) Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Japanese Encephalitis (JE) Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Japanese Encephalitis (JE) Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Japanese Encephalitis (JE) Vaccine Price by Type (2015-2020)
11 Global Japanese Encephalitis (JE) Vaccine Market Segment by Application
11.1 Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Japanese Encephalitis (JE) Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Japanese Encephalitis (JE) Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Japanese Encephalitis (JE) Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025)
12.2.2 Europe Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025)
12.2.4 South America Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025)
12.3 Japanese Encephalitis (JE) Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Japanese Encephalitis (JE) Vaccine Market Share Forecast by Type (2021-2025)
12.4 Japanese Encephalitis (JE) Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Japanese Encephalitis (JE) Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Japanese Encephalitis (JE) Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Japanese Encephalitis (JE) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Japanese Encephalitis (JE) Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Japanese Encephalitis (JE) Vaccine Major Business
Table 9. GSK Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Japanese Encephalitis (JE) Vaccine Product and Services
Table 12. GSK Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 14. Bharat Biotech Japanese Encephalitis (JE) Vaccine Major Business
Table 15. Bharat Biotech Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Bharat Biotech SWOT Analysis
Table 17. Bharat Biotech Japanese Encephalitis (JE) Vaccine Product and Services
Table 18. Bharat Biotech Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Wuhan Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 20. Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Major Business
Table 21. Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Wuhan Institute of Biological SWOT Analysis
Table 23. Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Product and Services
Table 24. Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Japanese Encephalitis (JE) Vaccine Major Business
Table 27. Sanofi Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Sanofi SWOT Analysis
Table 29. Sanofi Japanese Encephalitis (JE) Vaccine Product and Services
Table 30. Sanofi Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Valneva Basic Information, Manufacturing Base and Competitors
Table 32. Valneva Japanese Encephalitis (JE) Vaccine Major Business
Table 33. Valneva Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Valneva SWOT Analysis
Table 35. Valneva Japanese Encephalitis (JE) Vaccine Product and Services
Table 36. Valneva Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Chengdu institute of biologica Basic Information, Manufacturing Base and Competitors
Table 38. Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Major Business
Table 39. Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Chengdu institute of biologica SWOT Analysis
Table 41. Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Product and Services
Table 42. Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
Table 44. Liaoning Chengda Japanese Encephalitis (JE) Vaccine Major Business
Table 45. Liaoning Chengda Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Liaoning Chengda SWOT Analysis
Table 47. Liaoning Chengda Japanese Encephalitis (JE) Vaccine Product and Services
Table 48. Liaoning Chengda Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Beijing Taitan Basic Information, Manufacturing Base and Competitors
Table 50. Beijing Taitan Japanese Encephalitis (JE) Vaccine Major Business
Table 51. Beijing Taitan Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. Beijing Taitan SWOT Analysis
Table 53. Beijing Taitan Japanese Encephalitis (JE) Vaccine Product and Services
Table 54. Beijing Taitan Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Lanzhou Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 56. Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Major Business
Table 57. Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Lanzhou Institute of Biological SWOT Analysis
Table 59. Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Product and Services
Table 60. Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Biological E. Limited Basic Information, Manufacturing Base and Competitors
Table 62. Biological E. Limited Japanese Encephalitis (JE) Vaccine Major Business
Table 63. Biological E. Limited Japanese Encephalitis (JE) Vaccine Total Revenue (USD Million) (2017-2018)
Table 64. Biological E. Limited SWOT Analysis
Table 65. Biological E. Limited Japanese Encephalitis (JE) Vaccine Product and Services
Table 66. Biological E. Limited Japanese Encephalitis (JE) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Japanese Encephalitis (JE) Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 68. Global Japanese Encephalitis (JE) Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Japanese Encephalitis (JE) Vaccine Sales by Regions (2015-2020) (K Doses)
Table 70. Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Regions (2015-2020)
Table 71. Global Japanese Encephalitis (JE) Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Japanese Encephalitis (JE) Vaccine Sales by Countries (2015-2020) (K Doses)
Table 73. North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2015-2020)
Table 74. North America Japanese Encephalitis (JE) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2015-2020)
Table 76. Europe Japanese Encephalitis (JE) Vaccine Sales by Countries (2015-2020) (K Doses)
Table 77. Europe Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2015-2020)
Table 78. Europe Japanese Encephalitis (JE) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Japanese Encephalitis (JE) Vaccine Sales by Regions (2015-2020) (K Doses)
Table 80. Asia-Pacific Japanese Encephalitis (JE) Vaccine Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Japanese Encephalitis (JE) Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Japanese Encephalitis (JE) Vaccine Sales by Countries (2015-2020) (K Doses)
Table 83. South America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2015-2020)
Table 84. South America Japanese Encephalitis (JE) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Japanese Encephalitis (JE) Vaccine Sales by Countries (2015-2020) (K Doses)
Table 87. Middle East & Africa Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Japanese Encephalitis (JE) Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2015-2020)
Table 90. Global Japanese Encephalitis (JE) Vaccine Sales by Type (2015-2020) (K Doses)
Table 91. Global Japanese Encephalitis (JE) Vaccine Sales Share by Type (2015-2020)
Table 92. Global Japanese Encephalitis (JE) Vaccine Revenue by Type (2015-2020) (USD Million)
Table 93. Global Japanese Encephalitis (JE) Vaccine Revenue Share by Type (2015-2020)
Table 94. Global Japanese Encephalitis (JE) Vaccine Sales by Application (2015-2020) (K Doses)
Table 95. Global Japanese Encephalitis (JE) Vaccine Sales Share by Application (2015-2020)
Table 96. Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 97. Global Japanese Encephalitis (JE) Vaccine Market Share Forecast by Regions (2021-2025)
Table 98. Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 99. Global Japanese Encephalitis (JE) Vaccine Market Share Forecast by Type (2021-2025)
Table 100. Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Application (2021-2025)
Table 101. Global Japanese Encephalitis (JE) Vaccine Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Japanese Encephalitis (JE) Vaccine Picture
Figure 2. Global Sales Market Share of Japanese Encephalitis (JE) Vaccine by Type in 2019
Figure 3. Inactivated Vaccine Picture
Figure 4. Live Attenuated Vaccine Picture
Figure 5. Japanese Encephalitis (JE) Vaccine Sales Market Share by Application in 2018
Figure 6. Public Picture
Figure 7. Private Picture
Figure 8. Global Japanese Encephalitis (JE) Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Japanese Encephalitis (JE) Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Japanese Encephalitis (JE) Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Japanese Encephalitis (JE) Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 34. Global Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 48. Canada Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Mexico Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Europe Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. UK Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. France Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Russia Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Asia-Pacific Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Japanese Encephalitis (JE) Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Japanese Encephalitis (JE) Vaccine Revenue Market Share by Regions 2019
Figure 61. China Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Korea Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. India Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Southeast Asia Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. South America Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Japanese Encephalitis (JE) Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Japanese Encephalitis (JE) Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Egypt Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Turkey Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. South Africa Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Global Japanese Encephalitis (JE) Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 80. Global Japanese Encephalitis (JE) Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025) (K Doses)
Figure 82. Europe Sales Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025) (K Doses)
Figure 83. Asia-Pacific Sales Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025) (K Doses)
Figure 84. South America Sales Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. Middle East & Africa Sales Japanese Encephalitis (JE) Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel